介素-38:一种候选生物标志物,用于疾病严重程度在先进的脂肪性肝病的疾病严重性
Valeria Wagner1, Michael Mederer1, Barbara Enrich1
1Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Christoph-Probst-Platz 1, 6020 Innsbruck, Austria.
Cells
|February 12, 2026
概括
介素-38 (IL-38) 水平表明脂肪性肝病的严重程度. 较高的IL-38与较差的结果相关,这表明它有可能作为风险分层和监测SLD患者治疗有效性的生物标志物.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 介素-38 (IL-38) 是一种来自IL-1家族的抗炎细胞因子.
- 众所周知,IL-38通过其抗炎性质来限制组织损伤.
研究的目的:
- 评估IL-38在脂肪性肝病 (SLD) 中的诊断歧视.
- 评估IL-38在SLD患者的预后相关性.
主要方法:
- 184名SLD患者和8名健康对照患者的前性单心队列分析.
- 统计分析包括曼-惠特尼U,克鲁斯卡尔-瓦利斯,ROC曲线,物流回归,斯皮尔曼相关性,线性回归,卡普兰-梅尔和考克斯回归.
- 评估了IL-38,疾病严重程度 (MELD得分) 和常规实验室参数之间的关联.
主要成果:
- 与补偿患者相比,失补偿的SLD患者的IL-38度显著更高 (p < 0.001).
- IL-38与MELD得分呈正相关性 (p < 0.001),表明IL-38每增加1个MELD点的9.2%增加.
- 一个MELD + IL-38的组合模型实现了高的诊断准确性 (AUC ≈ 0.92).
结论:
- IL-38作为一种有价值的脂肪性肝病严重程度指标.
- IL-38显示出作为SLD早期风险分层的预测生物标志物的潜力.
- IL-38可能有助于监测脂肪性肝病的治疗干预措施.
相关概念视频
Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
208
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
208
Inflammatory Bowel Disease II: Crohn's Disease
1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases
2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.5K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
976
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
976


